Cite
HARVARD Citation
Al‐Batran, S. et al. (2021). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. International journal of cancer. 148 (6), pp. 1478-1488. [Online].